|
Urinary Bladder
|   |
|
Urinary Bladder
| |
Urinary Bladder - TURBT (SUBLT)
- For biopsies and transurethral resections with carcinoma of the urinary bladder.
Specimen and Surgical Procedure
Specimen, procedure.....................................................................
Tumor
Tumor site...................................................................................
Histologic type..............................................................................
Histologic grade............................................................................
Muscularis propria adequacy...........................present/absent/cannot be determined
Tumor extension...........................................................
Lymphovascular invasion.............................................................. present/absent
_____________________________________________________________________
Response Options to "Microscopic tumor extension"
___ Cannot be assessed
___ Noninvasive papillary carcinoma
___ Flat carcinoma in situ
___ Tumor invades lamina propria (subepithelial connective tissue)
___ Tumor invades muscularis propria (detrusor muscle)
___ Urothelial carcinoma involving prostatic urethra in prostatic chips sampled by TURBT
___ Urothelial carcinoma involving prostatic ducts and acini in prostatic chips sampled by TURBT
___ Urothelial carcinoma invasive into prostatic stroma in prostatic chips sampled by TURBT
(CAP Approved Genitourinary – Urinary Bladder 4.0.0.0)
Urinary Bladder - Cystectomy (SUBLR)
- For resection specimens with carcinoma of the urinary bladder. (Note: A cystoprostatectomy specimen may contain three separate primaries: carcinoma of the urinary bladder, carcinoma of the prostate and carcinoma of the urethra. Depending on the pathology in a given case, the number of protocols to be used in a cystoprostatectomy specimen will vary.)
Specimen and Surgical Procedure
Specimen, procedure.....................................................................
Lymph nodes submitted and/or identified in the specimen................... yes/no
Tumor
Tumor site...................................................................................
Tumor size...................................................................................
Histologic type..............................................................................
Histologic grade............................................................................
Tumor extension…………………...........................................................
Lymphovascular invasion.............................................................. present/absent
Final margins
Right proximal ureteral margin*..................................................... positive/negative
Left proximal ureteral margin*....................................................... positive/negative Distal urethral margin*................................................................. positive/negative
Deep soft tissue margin................................................................ positive/negative
Other margin(s) (if applicable, specify)........................................... positive/negative
*if carcinoma in situ/noninvasive high-grade/noninvasive low-grade urothelial carcinoma is identified at the margin, this MUST be specified
Note: For partial cystectomies, if the specimen is received unoriented precluding identification of specific margins, it should be denoted here.
Lymph Nodes
Regional lymph nodes involved......................................... __
Regional lymph nodes examined....................................... __
Pathologic stage (AJCC 8th ed.).................................................. pT__N__M__